Direct oral anticoagulants in the treatment of venous thromboembolism, with a focus on patients with pulmonary embolism: an evidence-based review

@inproceedings{GmezOutes2014DirectOA,
  title={Direct oral anticoagulants in the treatment of venous thromboembolism, with a focus on patients with pulmonary embolism: an evidence-based review},
  author={Antonio G{\'o}mez-Outes and Mª Luisa Su{\'a}rez-Gea and Ram{\'o}n Lecumberri and Ana Isabel Terleira-Fern{\'a}ndez and Emilio Vargas-Castrill{\'o}n},
  booktitle={Vascular health and risk management},
  year={2014}
}
Pulmonary embolism (PE) is a relatively common cardiovascular emergency. PE and deep vein thrombosis (DVT) are considered expressions of the same disease, termed as venous thromboembolism (VTE). In the present review, we describe and meta-analyze the efficacy and safety data available with the direct oral anticoagulants (DOAC; dabigatran, rivaroxaban, apixaban, edoxaban) in clinical trials testing these new compounds in the acute/long-term and extended therapy of VTE, providing subgroup… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 3 times. VIEW TWEETS

References

Publications referenced by this paper.
Showing 1-10 of 56 references

Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism.

The New England journal of medicine • 2013
View 5 Excerpts
Highly Influenced

Apixaban for extended treatment of venous thromboembolism.

The New England journal of medicine • 2013
View 2 Excerpts
Highly Influenced

Meta-analysis in clinical trials.

Controlled clinical trials • 1986
View 2 Excerpts
Highly Influenced

Meta-analysis of the efficacy and safety of new oral anticoagulants in patients with cancer-associated acute venous thromboembolism

T van der Hulle, PL den Exter, +3 authors FA. Klok
J Thromb Haemost • 2014
View 1 Excerpt

Similar Papers

Loading similar papers…